SCHEMBL7705120

SCHEMBL7705120

C=C1CCC2C3CCc4cc(OC)ccc4C3CC[C@]12C

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.77
HSD17B1 P14061 3/20 0.77
MAPT P10636 2/20 0.77
RECQL P46063 1/20 0.77
SMN1; SMN2 Q16637 1/20 0.77
HSD17B10 Q99714 2/20 0.65
ESR1 P03372 5/20 0.62
CYP3A4 P08684 4/20 0.60
CYP1A2 P05177 2/20 0.60
HIF1A Q16665 2/20 0.60
PGR P06401 2/20 0.60
SLC6A4 P31645 2/20 0.60
SLC6A3 Q01959 2/20 0.60
CYP2C19 P33261 1/20 0.60
NR3C1 P04150 1/20 0.60
CNR1 P21554 1/20 0.60
SLC6A2 P23975 1/20 0.60
STS P08842 5/20 0.59
KDM4E B2RXH2 2/20 0.58
ESR2 Q92731 2/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7705116 1.00 LMNA (0.77) LMNAHSD17B1MAPTRECQLSMN1; SMN2
SCHEMBL6462059 1.00 LMNA (0.77) LMNAHSD17B1MAPTRECQLSMN1; SMN2
Ethylene SCHEMBL11570544 0.87 HSD17B1 (0.95) LMNAHSD17B1MAPTRECQLSMN1; SMN2
SCHEMBL959954 0.87 HSD17B1 (1.00) LMNAHSD17B1MAPTRECQLSMN1; SMN2
SCHEMBL18658723 0.87 HSD17B1 (1.00) LMNAHSD17B1MAPTRECQLSMN1; SMN2
SCHEMBL4570835 0.87 HSD17B1 (1.00) LMNAHSD17B1MAPTRECQLSMN1; SMN2
SCHEMBL12441050 0.87 HSD17B1 (1.00) LMNAHSD17B1MAPTRECQLSMN1; SMN2
SCHEMBL15308964 0.87 HSD17B1 (1.00) LMNAHSD17B1MAPTRECQLSMN1; SMN2
SCHEMBL6671304 0.87 LMNA (0.75) LMNAHSD17B1MAPTRECQLSMN1; SMN2
SCHEMBL5677806 0.87 HSD17B1 (1.00) LMNAHSD17B1MAPTRECQLSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6352980-B1 ADMINISTERING BY SPRAYING IN NOSE PHERIN PHARMACEUTICALS, INC. 2002-03-05 US disclosed
US-6331534-B1 ADMINISTERING EFFECTIVE AMOUNT OF STEROID WITHIN NASAL PASSAGE OF INDIVIDUAL SUCH THAT IT BINDS SPECIFICALLY TO RECEPTORS ON SURFACE OF NASAL NEUROEPITHELIAL CELLS IN VOMERONASAL ORGAN PHERIN PHARMACEUTICALS, INC. 2001-12-18 US disclosed
US-6117860-A NASALLY ADMINISTERING STEROID WHICH BINDS TO A SPECIFIC NEUROEPITHELIAL RECEPTOR FOR ALLEVIATING PREMENSTRUAL TENSION AND ANXIETY PHERIN PHARMACEUTICALS, INC. (US) 2000-09-12 US disclosed
US-6066627-A ALTERING BLOOD CONCNETRATION OF LUTEINIZING HORMONE PHERIN CORPORATION (US) 2000-05-23 US disclosed
US-6057439-A EPOXYSTEROIDS PHERIN CORPORATION (US) 2000-05-02 US disclosed
EP-0783513-A4 NOVEL ESTRENES FOR INDUCING HYPOTHALAMIC EFFECTS PHERIN CORP (US) 2000-03-08 EP disclosed
US-5994568-A BIND TO NEUROEPITHELIAL RECEPTORS. PHERIN CORPORATION (US) 1999-11-30 US disclosed
US-5939570-A Estrenes for inducing hypothalamic effects PHERIN CORPORATION (US) 1999-08-17 US disclosed
US-5925774-A ESTRENE STEROIDS WHICH BIND TO NEUROEPITHELIAL RECEPTORS PHERIN CORPORATION (US) 1999-07-20 US disclosed
EP-0924219-A2 Novel estrenes for inducing hypothalamic effects PHERIN CORPORATION (US) 1999-06-23 EP disclosed
EP-0783513-A1 NOVEL ESTRENES FOR INDUCING HYPOTHALAMIC EFFECTS PHERIN CORPORATION (US) 1997-07-16 EP disclosed
US-5633392-A STIMULANTS FOR AUTONOMIC NERVOUS SYSTEM; NOSE SPRAYING PHERIN CORPORATION (US) 1997-05-27 US disclosed
WO-1996010032-A1 NOVEL ESTRENES FOR INDUCING HYPOTHALAMIC EFFECTS PHERIN CORPORATION (US) 1996-04-04 WO disclosed